DXCM · DexCom, Inc.
$70.142026-07-21Sector: Healthcare; Industry: Medical - Devices; Sub-Industry: Health Care Equipment
Intrinsic Value Range Comparison · Mulya.ai
R&D capitalized (5yr)Base · active
$60
-13.9% vs market
Mulya.ai vs Analyst IV Comparison?
Mulya.ai IV range ($47 · $63) Analysts Range ($64 · $95) Fundamentals · historical + forward · baseitalics = DCF projection
| Period | Revenue | Rev Gr ? | Ops M% ? | Tax Rate ? | NOPAT ? | Reinvest ? | FCFF ? | WACC% ? | PV FCFF ? | ROIC ? | Inv. Cap ? | EPS ? | P/E |
|---|
| 2024.Q1 | $3.6B | — | 19.2% | 17.9% | $572MM | −$197MM | $375MM | 9.9% | — | 17.7% | $3.2B | $1.38 | — |
| 2024.Q4 | $3.6B | 0.0% | 19.2% | 18.7% | $566MM | −$178MM | $388MM | 11.2% | — | 17.1% | $3.4B | $1.38 | — |
| 2025.Q1 | $4.0B | 11.3% | 17.3% | 26.8% | $512MM | −$233MM | $280MM | 10.5% | — | 14.7% | $3.6B | $1.46 | — |
| 2025.Q4 | $4.0B | 0.0% | 17.3% | 23.2% | $538MM | −$168MM | $370MM | 11.4% | — | 15.0% | $3.6B | $1.46 | — |
| 2026.Q1 | $4.8B | 19.5% | 25.0% | 22.7% | $931MM | −$17MM | $915MM | 10.5% | — | 26.5% | $3.5B | $2.36 | 22.9 |
| italics below = DCF projection · 10yr Rev CAGR: 9.5% |
| 2027.Q1 | $5.4B | +11.6% | 29.2% | 22.4% | $1.2B | −$418MM | $798MM | 9.4% | $730MM | 33.0% | $3.9B | $2.27 | 30.9 |
| 2028.Q1 | $6.0B | +11.5% | 27.5% | 22.2% | $1.3B | −$480MM | $803MM | 9.4% | $671MM | 31.0% | $4.4B | $2.46 | 28.5 |
| 2029.Q1 | $6.7B | +12.0% | 25.8% | 21.9% | $1.4B | −$575MM | $778MM | 9.3% | $595MM | 29.0% | $4.9B | $2.66 | 26.4 |
| 2030.Q1 | $7.5B | +12.3% | 24.1% | 21.6% | $1.4B | −$689MM | $736MM | 9.2% | $515MM | 26.9% | $5.6B | $2.89 | 24.3 |
| 2031.Q1 | $8.4B | +11.8% | 20.7% | 21.4% | $1.4B | −$771MM | $603MM | 9.1% | $387MM | 22.8% | $6.4B | $3.00 | 23.4 |
|
| Term. Yr+ | $12.4B | 4.1% | 20.7% | 20.0% | $2.1B | −$408MM | $1.6B | 8.6% | $15.4B | 20.7% | — | — | — |
Active scenario IV: $60 (-13.9% vs market)